155 related articles for article (PubMed ID: 16263104)
1. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice.
Saxena A; Sun W; Luo C; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():199-203. PubMed ID: 16263104
[TBL] [Abstract][Full Text] [Related]
2. Bioscavengers for the protection of humans against organophosphate toxicity.
Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase.
Allon N; Raveh L; Gilat E; Cohen E; Grunwald J; Ashani Y
Toxicol Sci; 1998 Jun; 43(2):121-8. PubMed ID: 9710953
[TBL] [Abstract][Full Text] [Related]
4. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization.
Raveh L; Grunwald J; Marcus D; Papier Y; Cohen E; Ashani Y
Biochem Pharmacol; 1993 Jun; 45(12):2465-74. PubMed ID: 8328984
[TBL] [Abstract][Full Text] [Related]
5. Effects of physostigmine and human butyrylcholinesterase on acoustic startle reflex and prepulse inhibition in C57BL/6J mice.
Clark MG; Sun W; Myers TM; Bansal R; Doctor BP; Saxena A
Pharmacol Biochem Behav; 2005 Jul; 81(3):497-505. PubMed ID: 15913750
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX.
Saxena A; Sun W; Fedorko JM; Koplovitz I; Doctor BP
Biochem Pharmacol; 2011 Jan; 81(1):164-9. PubMed ID: 20846507
[TBL] [Abstract][Full Text] [Related]
7. Safety and pharmacokinetics of human serum butyrylcholinesterase in guinea pigs.
Sun W; Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():428-9. PubMed ID: 16429577
[TBL] [Abstract][Full Text] [Related]
8. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.
Lenz DE; Yeung D; Smith JR; Sweeney RE; Lumley LA; Cerasoli DM
Toxicology; 2007 Apr; 233(1-3):31-9. PubMed ID: 17188793
[TBL] [Abstract][Full Text] [Related]
9. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
[TBL] [Abstract][Full Text] [Related]
10. Effect of polyethylene glycol conjugation on the circulatory stability of plasma-derived human butyrylcholinesterase in mice.
Sun W; Luo C; Tipparaju P; Doctor BP; Saxena A
Chem Biol Interact; 2013 Mar; 203(1):172-6. PubMed ID: 23220586
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycosylation prolongs the circulatory stability of recombinant human butyrylcholinesterase.
Chilukuri N; Parikh K; Sun W; Naik R; Tipparaju P; Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():115-21. PubMed ID: 16253215
[TBL] [Abstract][Full Text] [Related]
12. Polyethylene-glycol conjugated recombinant human acetylcholinesterase serves as an efficacious bioscavenger against soman intoxication.
Kronman C; Cohen O; Raveh L; Mazor O; Ordentlich A; Shafferman A
Toxicology; 2007 Apr; 233(1-3):40-6. PubMed ID: 17045722
[TBL] [Abstract][Full Text] [Related]
13. Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.
Cohen O; Kronman C; Raveh L; Mazor O; Ordentlich A; Shafferman A
Mol Pharmacol; 2006 Sep; 70(3):1121-31. PubMed ID: 16801396
[TBL] [Abstract][Full Text] [Related]
14. Amino acid residues at the N- and C-termini are essential for the folding of active human butyrylcholinesterase polypeptide.
Naik RS; Pattabiraman N; Patel KA; Doctor BP; Saxena A
Chem Biol Interact; 2013 Mar; 203(1):24-9. PubMed ID: 23044488
[TBL] [Abstract][Full Text] [Related]
15. Human plasma-derived butyrylcholinesterase is behaviorally safe and effective in cynomolgus macaques (Macaca fascicularis) challenged with soman.
Myers TM
Chem Biol Interact; 2019 Aug; 308():170-178. PubMed ID: 31129133
[TBL] [Abstract][Full Text] [Related]
16. A repeated injection of polyethyleneglycol-conjugated recombinant human butyrylcholinesterase elicits immune response in mice.
Chilukuri N; Sun W; Parikh K; Naik RS; Tang L; Doctor BP; Saxena A
Toxicol Appl Pharmacol; 2008 Sep; 231(3):423-9. PubMed ID: 18586293
[TBL] [Abstract][Full Text] [Related]
17. Next generation OP-bioscavengers: a circulatory long-lived 4-PEG hypolysine mutant of F338A-HuAChE with optimal pharmacokinetics and pseudo-catalytic characteristics.
Kronman C; Cohen O; Mazor O; Ordentlich A; Raveh L; Velan B; Shafferman A
Chem Biol Interact; 2010 Sep; 187(1-3):253-8. PubMed ID: 20005217
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human serum butyrylcholinesterase in rhesus monkeys: behavioral and physiological effects.
Myers TM; Sun W; Naik RS; Clark MG; Doctor BP; Saxena A
Neurotoxicol Teratol; 2012; 34(3):323-30. PubMed ID: 22402122
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of human butyrylcholinesterase pretreatment followed by acute soman challenge in cynomolgus monkeys.
Sun W; Doctor BP; Lenz DE; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):428-30. PubMed ID: 18674756
[TBL] [Abstract][Full Text] [Related]
20. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model.
Ashani Y; Pistinner S
Toxicol Sci; 2004 Feb; 77(2):358-67. PubMed ID: 14600276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
